Walgreen’s partnership with Village Medical—and its investment in micro-fulfillment technology—is crucial to Walgreen’s future in fulfilling its mission of caring for patients.
Janssen, the company’s pharmaceutical segment, will be named Johnson & Johnson Innovative Medicine, and the medical technology segment will continue to be named Johnson & Johnson MedTech.
Kellogg Company will be renamed Kellanova, and will continue to trade on the New York Stock Exchange under the ticker symbol "K," while WK Kellogg Co is expected to begin trading under the ticker symbol "KLG."
Ustekinumab is a fully human monoclonal antibody to interleukin (IL)-12/23, approved for treatment of plaque psoriasis, psoriatic arthritis, Crohn´s disease and ulcerative colitis.
